NBIX vs UNH
Neurocrine Biosciences vs UnitedHealth Group — AI-powered side-by-side comparison
| Metric | NBIX | UNH |
|---|---|---|
| AI Score | 66 | 52 |
| Price | $175.67 | $420.67 |
| P/E Ratio | 26.20× | 27.06× |
| ROE | 0.1% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 1.0% | 0.2% |
| Debt / Equity | 0.12× | 0.70× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 56.8 | 45.4 |
| Beta | 0.386 | 0.633 |
| Expected Upside | — | +31.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NBIX Full Analysis
UNH Full Analysis